Treatment
Medication clinical trials
We’re tracking 7,446 recruiting studies that include Medication, each written for real people, not researchers, below.
Recruiting studies
- NCT07000409Recruiting
Ultrasound-guided nerve block for shingles pain
This trial tests if a nerve block with betamethasone can reduce long-term shingles pain on the trunk. It may help people who still have pain more than 3 months after the rash appeared.
CairoAges 18–75 - NCT07000682RecruitingEarly Phase 1
UTAA91 injection for systemic sclerosis study
This trial tests a new treatment, UTAA91 injection, for people with moderate-to-severe systemic sclerosis that hasn't improved with standard therapies. It may offer an option when other treatments have failed or aren't available.
Wuhan, HubeiAges 18 years+ - NCT07000656Recruiting
Bladder training device for children with urinary problems
This trial tests a device that helps children with nighttime bedwetting, daytime urine leaks, or frequent urgent urination by teaching them to relax and control their bladder. It aims to improve symptoms without medication.
Shanghai, Shanghai MunicipalityAges 5–18 - NCT07000916Recruiting
Follow-up study for new arthritis in kids and young adults
This study follows children and young adults newly diagnosed with certain types of arthritis or related conditions to learn more about their health over time. It may help doctors better understand how these diseases progress and how treatments work.
BrusselsAges 2–50 - NCT07001085Recruiting
Blood test to monitor liver cancer after surgery
This study uses a simple blood test to monitor tiny pieces of tumor DNA (ctDNA) in people with colorectal cancer that spread to the liver or with liver cancer (HCC), before and after liver surgery or transplant. It aims to help doctors detect cancer return earlier and guide treatment.
Warsaw, Masovian VoivodeshipAges 18–75 - NCT07001852Recruiting
Endovascular therapy for late window stroke patients selected by automated CT
This trial tests whether removing a clot from a large brain artery up to 72 hours after a stroke helps people recover better than standard care. It uses a special computer program on a regular CT scan to decide who might benefit.
Iowa City, IowaAges 18–80 - NCT07001956RecruitingEarly Phase 1
UTAA91 injection for difficult rheumatoid arthritis
This trial tests a new injection called UTAA91 for people with hard-to-treat rheumatoid arthritis. It's for those who have tried standard treatments without success.
Wuhan, HubeiAges 18 years+ - NCT07002827Recruiting
Growth factors for early decompensated cirrhosis
This study tests whether a combination of two medicines (G-CSF and darbepoetin) given in one or more cycles can improve the body's immune and metabolic health in people with early-stage decompensated cirrhosis (advanced liver disease with mild complications). It compares these treatments with standard medical care.
New Delhi, National Capital Territory of DelhiAges 18–70 - NCT07002801Recruiting
Remimazolam and Esketamine for Older Adults Having Painless Stomach and Colon Scope
This trial tests a combination of two sedative medicines (Remimazolam and Esketamine) for elderly patients having a painless stomach and colon exam. The goal is to see if this combination is safe and effective for older adults.
Harbin, HeilongjiangAges 65 years+ - NCT07003100Recruiting
Studying mogamulizumab rash in mycosis fungoides or sezary syndrome
This study looks at a common skin rash caused by the drug mogamulizumab in patients with certain types of lymphoma. It aims to learn more about the rash and how to manage it, so your experience can help future patients.
Duarte, CaliforniaAges 18 years+ - NCT07003334Recruiting
Study on mental health and immune therapy for stomach cancer
This study looks at how psychological distress relates to immune checkpoint inhibitors in people with stomach cancer. It may help understand if emotional well-being affects treatment response.
Guangzhou, GuangdongAges 18–75 - NCT07003399Recruiting
Breathing Muscle Function in Sleep Apnea and COPD
This study looks at how the diaphragm (the main breathing muscle) and the drive to breathe work in people with sleep apnea, COPD, or both. Researchers want to compare these groups with healthy volunteers to better understand breathing problems.
Nanjing, JiangsuAges 18–80 - NCT07003841Recruiting
AR-guided breast cancer localization trial
This trial tests an augmented reality (AR) tool to help surgeons locate breast cancer tumors during breast-conserving surgery. You may join if you have a single, small invasive breast tumor and have not had chemotherapy before surgery.
Seoul, Gangseo-guAges 19–80 - NCT07005141Recruiting
iHub Stent-Graft for Iliac Artery Aneurysms
This study tests a new stent-graft device for treating aneurysms in the iliac artery. It may be an option if you have an aneurysm that has grown or is large enough to need treatment.
Florianópolis, Santa CatarinaAges 18 years+ - NCT07005453Recruiting
Studying a new way to measure polyp size during colonoscopy
This trial tests a tool that helps doctors more accurately measure the size of polyps found during colonoscopy. Accurate measurement helps decide the best next steps for your care.
Eindhoven, North BrabantAges 55–80 - NCT07005505Recruiting
Comparing two breathing trial methods for ICU patients on ventilators
This study compares two ways to help patients breathe on their own during a spontaneous breathing trial (a test to see if they can come off the ventilator). It aims to find which method works better for adults in the ICU.
Chicago, IllinoisAges 18 years+ - NCT07006493Recruiting
Radiofrequency ablation for obstructive hypertrophic cardiomyopathy
This trial tests a new treatment that uses radiofrequency energy (similar to heat) to shrink the thickened heart muscle blocking blood flow. It is for people with obstructive hypertrophic cardiomyopathy who have symptoms despite medication and are not able or willing to have heart surgery.
Beijing, Beijing MunicipalityAges 18–80 - NCT07007143RecruitingPhase 4
Blood thinner study after heart valve repair
This trial tests different blood-thinning medicines after a mitral valve repair procedure (TEER) in people who do not need long-term blood thinners. It aims to find the safest and most effective strategy to prevent blood clots.
Beijing, Beijing MunicipalityAges Any age - NCT07008391Recruiting
High-sensitivity troponin test in ambulance care
This trial tests whether using a high-sensitivity troponin I test in the ambulance, along with standard care, can help emergency medical services better identify heart attacks. This might lead to faster treatment for patients with chest pain or suspected heart attack.
Stockholm, ÅrstaAges 18 years+ - NCT07009236Recruiting
MINIject S+ for open angle glaucoma
This trial tests a tiny implant called MINIject S+ to lower eye pressure in people with open angle glaucoma that isn't well controlled with eye drops. It may be done alone or with cataract surgery.
Santa Rosa de CopánAges 20 years+ - NCT07009418Recruiting
CT scan vs. usual care after heart stent or balloon treatment
This trial tests whether a CT scan of the heart arteries is a safe and effective alternative to standard follow-up tests in people who have had a stent or drug-coated balloon placed in a high-risk coronary artery. It may help reduce the need for additional invasive procedures.
Bucheon-siAges 19 years+ - NCT07009665Recruiting
Fluid management in sepsis patients at the emergency department
This study tests a personalized approach to giving fluids to patients with sepsis, a serious infection that can cause low blood pressure. The goal is to see if individualized fluid resuscitation improves outcomes compared to standard care.
Groningen, Provincie GroningenAges 18 years+ - NCT07009704Recruiting
Glucose monitoring and support in pregnancy study
This study tests whether using a continuous glucose monitor (a small sensor that tracks your blood sugar) along with support from others can help prevent or manage high blood sugar during pregnancy. It is for pregnant women under 20 weeks who have certain risk factors for gestational diabetes.
Boston, MassachusettsAges 18–45 - NCT07010029Recruiting
Heart vein device for angina with no blocked arteries
This trial tests a special device placed in a vein of the heart to help patients who have chest pain (angina) but no major blockages in their heart arteries. It is designed for people who have tried maximum medications but still have symptoms.
WarsawAges 18 years+
Common questions
- Are there clinical trials studying Medication?
- Yes. Clin2 currently lists 7,446 recruiting studies that include Medication, drawn from the U.S. registry and rewritten for real people so you can see what each is testing and who it's for.
- How do I know if I qualify for a Medication trial?
- Each study lists its own eligibility criteria — rules about condition, age, and prior treatments. On every Clin2 trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Is Medication an approved treatment?
- A drug being studied in a trial may be investigational (still being tested) or already approved and being studied for a new use. Each study page explains what phase it's in. Clin2 does not provide medical advice — talk with your doctor about whether Medication or a specific trial is right for you.
Related treatments
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. A drug appearing here is being studied in a trial and may be investigational. Talk with your doctor about whether a specific treatment or trial is right for you.